EPO Patents = 5

Trademarks = 2

Forward Citations = 2

Loading Chart...

10 inventors (with patents filed for the assignee):

Nils Aage Brünner (2 out of 5 patents)

Jan Stenvang (2 out of 3 patents)

Palle Christophersen (2 out of 41 patents)

4. Jens Lichtenberg (2 out of 2 patents)

5. Annemette Thougaard (2 out of 2 patents)

6. Steffen Rump (1 out of 1 patent)

7. Henning Weigt (1 out of 1 patent)

8. Vadim Albertovich Makarov (1 out of 5 patents)

9. Peter Wutzler (1 out of 2 patents)

10. Michaela Schmidtke (1 out of 3 patents)

11. Lorraine Sharp (1 patent)

12. René Egebro (0 patent)

13. Peter Wutzler (0 patent)

14. Kaare G Rasmussen (0 patent)

15. Kiara Lobato (0 patent)

4 patents: Sort by Forward Citations

1. 11903927 - Combination treatment of cancer (2024-02-20),

2. 11103481 - Combination treatment of cancer (2021-08-31),

3. 10975079 - 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments (2021-04-13),

4. 9790225 - 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances (2017-10-17),

Scandion Oncology A/S is a clinical stage oncology company developing innovative therapies to increase the survival of cancer patients. The company's lead drug candidate, SCO-101, is designed to overcome drug resistance in cancer cells, with the potential to enhance the efficacy of existing cancer treatments. Scandion Oncology aims to improve outcomes for patients with difficult-to-treat cancers through its cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#60 in Copenhagen

#545 in Denmark

Copenhagen, Denmark

Scandion Oncology A/s